Clinical trialNCT04051502CompletedEarly phase 1Interventional

ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study

SponsorMemorial Sloan Kettering Cancer CenterEnrollment48Adnexal MassOvarian Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to find out how well ovarian sentinel lymph nodes (SLNs) can be identified with indocyanine green (ICG) dye during risk-reducing ovarian surgery.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Ginger Gardner, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Memorial Sloan Kettering Basking Ridge (consent Only)
Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (consent Only)
Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (consent Only )
Montvale, New Jersey, United States
Memorial Sloan Kettering Commack (consent Only)
Commack, New York, United States
Memorial Sloan Kettering Westchester (consent Only)
Harrison, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Memorial Sloan Kettering Nassau (consent Only)
Uniondale, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Method 1: Indocyanine green dyeMethod 2: Indocyanine green dyeMethod 3: Indocyanine green dye

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 5 Aug 2019
Primary completion: 8 Dec 2025
Completion: 8 Dec 2025
Last update posted: 17 Dec 2025
Registered enrollment: 48
Registry id: NCT04051502

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.